IMPROVED SURVIVAL WITH IPILIMUMAB IN PATIENTS WITH ADVANCED MELANOMA IN REAL-WORLD CLINICAL PRACTICE: FIRST RESULTS OF THE DUTCH MELANOMA TREATMENT REGISTRY

被引：1
|
作者：
Leeneman, B. [1 ]
Franken, M. G. [2 ]
Jochems, A. [3 ]
Schouwenburg, M. G. [4 ]
Wouters, M. W. [5 ]
Van den Eertwegh, A. J. [6 ]
Haanen, J. B. [5 ]
Van der Hoeven, K. J. [3 ]
Uyl-de Groot, C. A. [2 ]
机构：
[1] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
[2] Erasmus Univ, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Leiden, Netherlands
[4] Dutch Inst Clin Auditing, Deventer, Netherlands
[5] Netherlands Canc Inst, Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN62
引用
收藏
页码：A440 / A440
页数：1
相关论文
共 50 条
  • [1] Real-world treatment practice in patients with advanced melanoma
    Cybulska-Stopa, Bozena
    Piejko, Karolina
    Pacholczak, Renata
    Domagata-Haduch, Malgorzata
    Drosik-Kwasniewska, Anna
    Rolski, Janusz
    Wiktor-Mucha, Patrycja
    Zemetka, Tomasz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2020, 24 (02): : 118 - 124
  • [2] Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study
    Middleton, Mark R.
    Dalle, Stephane
    Claveau, Joel
    Mut, Pilar
    Hallmeyer, Sigrun
    Plantin, Patrice
    Highley, Martin
    Kotapati, Srividya
    Le, Trong Kim
    Brokaw, Jane
    Abernethy, Amy P.
    CANCER MEDICINE, 2016, 5 (07): : 1436 - 1443
  • [3] Survival in BRAF-mutant metastatic melanoma in the real-world setting: results from the Dutch Melanoma Treatment Registry
    Schouwenburg, M.
    Jochems, A.
    Aarts, M.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Franken, M.
    Groenewegen, G.
    de Groot, J-W.
    Haanen, J. B. A. G.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    Ten Tije, A. J.
    Vreugdenhil, G.
    Wouters, M.
    van der Hoeven, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Real-world survival results of metastatic melanoma patients treated with ipilimumab in the Netherlands
    Jochems, A.
    Schouwenburg, M.
    Aarts, M.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Groenewegen, G.
    de Groot, J-W.
    Haanen, J. B. A. G.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kruit, W.
    Leeneman, B.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    Ten Tije, A. J.
    Vreugdenhil, G.
    Wouters, M.
    van der Hoeven, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] REAL-WORLD OUTCOMES OF IPILIMUMAB IN PATIENTS WITH ADVANCED MELANOMA IN THE NETHERLANDS
    Leeneman, B.
    Jochems, A.
    Schouwenburg, M.
    Aarts, M.
    van Akkooi, A.
    van den Berkmortel, F.
    van den Eertwegh, A.
    Groenewegen, G.
    de Groot, J.
    Haanen, J.
    van der Hoeven, J.
    Hospers, G.
    Kapiteijn, H.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    ten Tije, A.
    Vreugdenhil, G.
    Wouters, M.
    van Zeijl, M.
    Franken, M.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2016, 19 (07) : A708 - A709
  • [6] HEALTHCARE COSTS OF IPILIMUMAB IN PATIENTS WITH ADVANCED CUTANEOUS MELANOMA IN DUTCH CLINICAL PRACTICE
    Franken, M.
    Leeneman, B.
    Jochems, A.
    Schouwenburg, M.
    Aarts, M.
    van Akkooi, A.
    van den Berkmortel, F.
    van den Eertwegh, A.
    de Groot, J.
    van der Hoeven, J.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kmit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    Suijkerbuijk, K.
    ten Tije, A.
    Vreugdenhil, G.
    Wouters, M.
    van Zeijl, M.
    Haanen, J.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2017, 20 (09) : A431 - A431
  • [7] QUALITY OF LIFE IN ADVANCED MELANOMA: RESULTS OF THE DUTCH MELANOMA TREATMENT REGISTRY
    Franken, M.
    Leeneman, B.
    Schouwenburg, M.
    Jochems, A.
    Aarts, M.
    van Akkooi, A.
    van den Berkmortel, F.
    van, den Eertwegh A.
    Groenewegen, G.
    de Groot, J.
    Haanen, J.
    Hospers, G.
    Kapiteijn, E.
    Koornstra, R.
    Kruit, W.
    Louwman, M.
    Piersma, D.
    van Rijn, R.
    ten Tije, A.
    Vreugdenhil, G.
    Wouters, M.
    van Zeijl, M.
    van der Hoeven, J.
    Uyl-de Groot, C.
    VALUE IN HEALTH, 2016, 19 (07) : A747 - A747
  • [8] Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands
    Franken, Margreet G.
    Leeneman, Brenda
    Jochems, Anouk
    Schouwenburg, Maartje G.
    Aarts, Maureen J. B.
    van Akkooi, Alexander C. J.
    van den Berkmortel, Franchette W. P. . J.
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    van der Hoeven, Koos J. M.
    Hospers, Geke A. P.
    Kapiteijn, Ellen
    Koornstra, Rutger
    Kruit, Wim H. J.
    Louwman, Marieke W. J.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    van Zeijl, Michiel
    Haanen, John B. A. G.
    Uyl-de Groot, Carin A.
    ANTI-CANCER DRUGS, 2018, 29 (06) : 579 - 588
  • [9] Real-world outcomes in advanced melanoma patients treated with first-line nivolumab plus ipilimumab
    Kozak, Katarzyna
    Teterycz, Pawel
    Galus, Lukasz
    Mackiewicz, Jacek
    Galwas-Kliber, Katarzyna
    Kaminska-Winciorek, Grazyna
    Brandys, Piotr
    Cybulska-Stopa, Bozena
    Kempa-Kaminska, Natasza
    Zietek, Marcin
    Zubrowska, Justyna
    Dziura, Robert
    Dembinski, Mateusz
    Bereza, Michal
    Czarnecka, Anna Malgorzata
    Rutkowski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma
    Khoja, Leila
    Atenafu, Eshetu G.
    Ye, Qian
    Gedye, Craig
    Chappell, Maryanne
    Hogg, David
    Butler, Marcus O.
    Joshua, Anthony M.
    ONCOLOGY LETTERS, 2016, 11 (02) : 1581 - 1585
12345